HLHe Li

He Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


He Li has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Yu

    Department of Orthopedics, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China

    2 shared publications
  • Xiaoming Li

    Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, 100083, P. R. China

    2 shared publications
  • Yan Chen

    Department of Ultrasonic Diagnosis, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China

    2 shared publications
  • Bomiao Lin

    Department of Radiology

    1 shared publication
  • Huajun Li

    The Second Clinical Medical College of Southern Medical University, Guangzhou 510282, China

    1 shared publication
  • Huiting Tan

    The Second Clinical Medical College of Southern Medical University, Guangzhou 510282, China

    1 shared publication

Latest Publications

  • Open Access

    Application of Ultrasound on Monitoring the Evolution of the Collagen Fiber Reinforced nHAC/CS CompositesIn Vivo

    by Yan Chen, Yuting Yan, Xiaoming Li, He Li, Huiting Tan, Huajun Li, Yanwen Zhu, Philipp Niemeyer, Matin Yaega, Bo Yu

    To date, fiber reinforce scaffolds have been largely applied to repair hard and soft tissues. Meanwhile, monitoring the scaffolds for long periodsin vivois recognized as a crucial issue before its wide use. As a consequence, there is a growing need for noninvasive and convenient methods to analyze the implantation remolding processin situand in real time. In this paper, diagnostic medical ultrasound was used to monitor thein vivobone formation and degradation process of the novel mineralized collagen fiber reinforced composite which is synthesized by chitosan (CS), nanohydroxyapatite (nHA), and collagen fiber (Col). To observe the impact of cells on bone remodeling process, the scaffolds were planted into the back of the SD rats with and without rat bone mesenchymal stem cells (rBMSCs). Systematic data of scaffoldsin vivowas extracted from ultrasound images. Significant consistency between the data from the ultrasound and DXA could be observedP<0.05. This indicated that ultrasound may serve as a feasible alternative for noninvasive monitoring the evolution of scaffoldsin situduring cell growth.


  • Open Access

    Osteogenesis Capability and Degradation Property Evaluation of Injectable Biomaterials: Comparison of Computed Tomography and Ultrasound

    by Yan Chen, Yuting Yan, Xiaoming Li, He Li, Yue Yuan, Xiaoying Gao, Xixi Wu, Jisheng Zhong, Bomiao Lin, Yubo Fan, et al.

    Injectable biomaterials, which can be physically inserted into a target site without the use of surgery, have received increasing attention in tissue engineering during the last decade. There is also a growing need for quantitative evaluation of the injectable biomaterial directly and noninvasively. The objectives of this study are to originate a quantitative noninvasive technique for evaluation of in situ forming bone biomaterials and to validate the feasibility of diagnostic ultrasound images analysis technique. The potential of ultrasound for quantitative evaluation of tissue development was compared with computed tomography (CT) in vivo. A strong correlation was witnessed between ultrasound gray‐scale values (GV) and volumetric mean of CT value (HUm) (r = 0.95). Meanwhile, the volume of the material area could be estimated by ultrasound maximum cross‐section pixel, which demonstrates a certain consistency with CT mask volume in 3D reconstruction images (r = 0.87). In conclusion, ultrasound imaging, which is corresponding with the traditional CT, can be used to evaluate osteogenesis capability and degradation property of injectable biomaterials. It may be a noninvasive, nonradioactive, and effective aid to monitor ossification and reconstruction of biomaterials at the implant region for bone defect repair.